Wednesday, February 15, 2017 4:28:30 PM
"For the most part I"m running the clinical trials at this institution. One of those clinical trials is the theralase 1433 1b. So to speak to what Dr. Jewett said, this is a safety trial.
16:04
Here is the official title of the 1b safety trial.
Study Type:
Interventional
Study Design:
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title:
A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients With Non-muscle Invasive Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin Therapy and Who Are Medically Unfit for/Refuse Cystectomy
https://clinicaltrials.gov/ct2/show/NCT03053635?term=1433&rank=1
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM